<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/1999/REC-html401-19991224/loose.dtd">
<html><head><title>Report for REST 1549053414829 [GSEA]</title><link href='xtools.css' rel='stylesheet'><link href='http://www.gsea-msigdb.org/gsea/images/XBench.gif' rel='shortcut icon'></head><body><div class='richTable'><table cols='11' border='1'><th class='richTable'></th><th class='richTable'>GS<br> follow link to MSigDB</th><th class='richTable'>GS DETAILS</th><th class='richTable'>SIZE</th><th class='richTable'>ES</th><th class='richTable'>NES</th><th class='richTable'>NOM p-val</th><th class='richTable'>FDR q-val</th><th class='richTable'>FWER p-val</th><th class='richTable'>RANK AT MAX</th><th class='richTable'>LEADING EDGE</th><tr><td class='lessen'>1</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP'>WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP</a></td><td><a href='WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP.html'>Details ...</a></td><td>25</td><td>0.60</td><td>2.72</td><td>0.000</td><td>0.001</td><td>0.001</td><td>126</td><td>tags=80%, list=31%, signal=109%</td></tr><tr><td class='lessen'>2</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP'>KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP</a></td><td><a href='KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP.html'>Details ...</a></td><td>33</td><td>0.49</td><td>2.38</td><td>0.000</td><td>0.004</td><td>0.007</td><td>129</td><td>tags=70%, list=32%, signal=94%</td></tr><tr><td class='lessen'>3</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/KIM_WT1_TARGETS_UP'>KIM_WT1_TARGETS_UP</a></td><td><a href='KIM_WT1_TARGETS_UP.html'>Details ...</a></td><td>15</td><td>0.64</td><td>2.32</td><td>0.000</td><td>0.006</td><td>0.015</td><td>107</td><td>tags=80%, list=26%, signal=105%</td></tr><tr><td class='lessen'>4</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP'>BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP</a></td><td><a href='BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP.html'>Details ...</a></td><td>19</td><td>0.58</td><td>2.31</td><td>0.000</td><td>0.005</td><td>0.015</td><td>129</td><td>tags=79%, list=32%, signal=110%</td></tr><tr><td class='lessen'>5</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP'>CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP</a></td><td><a href='CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP.html'>Details ...</a></td><td>16</td><td>0.59</td><td>2.24</td><td>0.000</td><td>0.009</td><td>0.036</td><td>129</td><td>tags=81%, list=32%, signal=115%</td></tr><tr><td class='lessen'>6</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/CHEN_METABOLIC_SYNDROM_NETWORK'>CHEN_METABOLIC_SYNDROM_NETWORK</a></td><td><a href='CHEN_METABOLIC_SYNDROM_NETWORK.html'>Details ...</a></td><td>59</td><td>0.38</td><td>2.17</td><td>0.000</td><td>0.014</td><td>0.068</td><td>123</td><td>tags=54%, list=30%, signal=67%</td></tr><tr><td class='lessen'>7</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/SANSOM_APC_TARGETS_DN'>SANSOM_APC_TARGETS_DN</a></td><td><a href='SANSOM_APC_TARGETS_DN.html'>Details ...</a></td><td>19</td><td>0.52</td><td>2.12</td><td>0.000</td><td>0.018</td><td>0.100</td><td>67</td><td>tags=53%, list=17%, signal=60%</td></tr><tr><td class='lessen'>8</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP'>BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP</a></td><td><a href='BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP.html'>Details ...</a></td><td>22</td><td>0.49</td><td>2.08</td><td>0.002</td><td>0.023</td><td>0.145</td><td>115</td><td>tags=68%, list=28%, signal=90%</td></tr><tr><td class='lessen'>9</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY'>ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY</a></td><td><a href='ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY.html'>Details ...</a></td><td>24</td><td>0.46</td><td>2.05</td><td>0.002</td><td>0.026</td><td>0.172</td><td>119</td><td>tags=63%, list=29%, signal=83%</td></tr><tr><td class='lessen'>10</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/SMID_BREAST_CANCER_NORMAL_LIKE_UP'>SMID_BREAST_CANCER_NORMAL_LIKE_UP</a></td><td><a href='SMID_BREAST_CANCER_NORMAL_LIKE_UP.html'>Details ...</a></td><td>17</td><td>0.52</td><td>2.00</td><td>0.003</td><td>0.034</td><td>0.250</td><td>151</td><td>tags=76%, list=37%, signal=117%</td></tr><tr><td class='lessen'>11</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN'>RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN</a></td><td><a href='RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN.html'>Details ...</a></td><td>20</td><td>0.49</td><td>2.00</td><td>0.002</td><td>0.032</td><td>0.259</td><td>126</td><td>tags=70%, list=31%, signal=97%</td></tr><tr><td class='lessen'>12</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_HEMOSTASIS'>REACTOME_HEMOSTASIS</a></td><td><a href='REACTOME_HEMOSTASIS.html'>Details ...</a></td><td>15</td><td>0.53</td><td>1.98</td><td>0.004</td><td>0.032</td><td>0.277</td><td>188</td><td>tags=93%, list=46%, signal=168%</td></tr><tr><td class='lessen'>13</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/MULLIGHAN_MLL_SIGNATURE_1_UP'>MULLIGHAN_MLL_SIGNATURE_1_UP</a></td><td><a href='MULLIGHAN_MLL_SIGNATURE_1_UP.html'>Details ...</a></td><td>19</td><td>0.48</td><td>1.98</td><td>0.007</td><td>0.031</td><td>0.284</td><td>135</td><td>tags=68%, list=33%, signal=98%</td></tr><tr><td class='lessen'>14</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HAN_SATB1_TARGETS_DN'>HAN_SATB1_TARGETS_DN</a></td><td><a href='HAN_SATB1_TARGETS_DN.html'>Details ...</a></td><td>24</td><td>0.45</td><td>1.98</td><td>0.002</td><td>0.029</td><td>0.291</td><td>116</td><td>tags=63%, list=29%, signal=82%</td></tr><tr><td class='lessen'>15</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/JOHNSTONE_PARVB_TARGETS_3_UP'>JOHNSTONE_PARVB_TARGETS_3_UP</a></td><td><a href='JOHNSTONE_PARVB_TARGETS_3_UP.html'>Details ...</a></td><td>30</td><td>0.41</td><td>1.96</td><td>0.002</td><td>0.031</td><td>0.327</td><td>137</td><td>tags=67%, list=34%, signal=93%</td></tr><tr><td class='lessen'>16</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP'>RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP</a></td><td><a href='RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP.html'>Details ...</a></td><td>31</td><td>0.40</td><td>1.96</td><td>0.009</td><td>0.030</td><td>0.336</td><td>126</td><td>tags=61%, list=31%, signal=82%</td></tr><tr><td class='lessen'>17</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/MARSON_BOUND_BY_FOXP3_STIMULATED'>MARSON_BOUND_BY_FOXP3_STIMULATED</a></td><td><a href='MARSON_BOUND_BY_FOXP3_STIMULATED.html'>Details ...</a></td><td>39</td><td>0.37</td><td>1.92</td><td>0.007</td><td>0.038</td><td>0.423</td><td>131</td><td>tags=54%, list=32%, signal=72%</td></tr><tr><td class='lessen'>18</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/WIERENGA_STAT5A_TARGETS_UP'>WIERENGA_STAT5A_TARGETS_UP</a></td><td><a href='WIERENGA_STAT5A_TARGETS_UP.html'>Details ...</a></td><td>16</td><td>0.49</td><td>1.88</td><td>0.002</td><td>0.045</td><td>0.503</td><td>21</td><td>tags=38%, list=5%, signal=38%</td></tr><tr><td class='lessen'>19</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/GOZGIT_ESR1_TARGETS_DN'>GOZGIT_ESR1_TARGETS_DN</a></td><td><a href='GOZGIT_ESR1_TARGETS_DN.html'>Details ...</a></td><td>26</td><td>0.42</td><td>1.88</td><td>0.009</td><td>0.043</td><td>0.508</td><td>116</td><td>tags=62%, list=29%, signal=81%</td></tr><tr><td class='lessen'>20</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN'>RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN</a></td><td><a href='RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN.html'>Details ...</a></td><td>23</td><td>0.43</td><td>1.87</td><td>0.009</td><td>0.044</td><td>0.532</td><td>126</td><td>tags=65%, list=31%, signal=89%</td></tr><tr><td class='lessen'>21</td><td>SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN</td><td></td><td>31</td><td>0.39</td><td>1.87</td><td>0.007</td><td>0.045</td><td>0.558</td><td>230</td><td>tags=94%, list=57%, signal=200%</td></tr><tr><td class='lessen'>22</td><td>KEGG_LYSOSOME</td><td></td><td>15</td><td>0.50</td><td>1.86</td><td>0.010</td><td>0.045</td><td>0.579</td><td>126</td><td>tags=67%, list=31%, signal=93%</td></tr><tr><td class='lessen'>23</td><td>ENK_UV_RESPONSE_KERATINOCYTE_UP</td><td></td><td>26</td><td>0.41</td><td>1.85</td><td>0.003</td><td>0.044</td><td>0.583</td><td>78</td><td>tags=50%, list=19%, signal=58%</td></tr><tr><td class='lessen'>24</td><td>BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B</td><td></td><td>18</td><td>0.47</td><td>1.84</td><td>0.007</td><td>0.047</td><td>0.617</td><td>73</td><td>tags=56%, list=18%, signal=65%</td></tr><tr><td class='lessen'>25</td><td>CUI_TCF21_TARGETS_2_DN</td><td></td><td>25</td><td>0.41</td><td>1.83</td><td>0.008</td><td>0.047</td><td>0.631</td><td>143</td><td>tags=64%, list=35%, signal=93%</td></tr><tr><td class='lessen'>26</td><td>WONG_ADULT_TISSUE_STEM_MODULE</td><td></td><td>24</td><td>0.41</td><td>1.83</td><td>0.015</td><td>0.048</td><td>0.652</td><td>52</td><td>tags=42%, list=13%, signal=45%</td></tr><tr><td class='lessen'>27</td><td>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3</td><td></td><td>24</td><td>0.41</td><td>1.82</td><td>0.008</td><td>0.048</td><td>0.662</td><td>118</td><td>tags=58%, list=29%, signal=77%</td></tr><tr><td class='lessen'>28</td><td>NUYTTEN_EZH2_TARGETS_UP</td><td></td><td>38</td><td>0.36</td><td>1.82</td><td>0.009</td><td>0.047</td><td>0.682</td><td>137</td><td>tags=61%, list=34%, signal=83%</td></tr><tr><td class='lessen'>29</td><td>MULLIGHAN_MLL_SIGNATURE_2_UP</td><td></td><td>20</td><td>0.43</td><td>1.81</td><td>0.010</td><td>0.048</td><td>0.701</td><td>135</td><td>tags=65%, list=33%, signal=93%</td></tr><tr><td class='lessen'>30</td><td>SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP</td><td></td><td>21</td><td>0.43</td><td>1.80</td><td>0.007</td><td>0.051</td><td>0.734</td><td>107</td><td>tags=67%, list=26%, signal=86%</td></tr><tr><td class='lessen'>31</td><td>SENESE_HDAC1_TARGETS_UP</td><td></td><td>15</td><td>0.47</td><td>1.79</td><td>0.017</td><td>0.052</td><td>0.742</td><td>84</td><td>tags=53%, list=21%, signal=65%</td></tr><tr><td class='lessen'>32</td><td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN</td><td></td><td>18</td><td>0.44</td><td>1.77</td><td>0.016</td><td>0.058</td><td>0.811</td><td>83</td><td>tags=56%, list=20%, signal=67%</td></tr><tr><td class='lessen'>33</td><td>NABA_MATRISOME</td><td></td><td>18</td><td>0.44</td><td>1.77</td><td>0.014</td><td>0.057</td><td>0.811</td><td>73</td><td>tags=56%, list=18%, signal=65%</td></tr><tr><td class='lessen'>34</td><td>WALLACE_PROSTATE_CANCER_RACE_UP</td><td></td><td>17</td><td>0.44</td><td>1.72</td><td>0.016</td><td>0.076</td><td>0.906</td><td>107</td><td>tags=59%, list=26%, signal=77%</td></tr><tr><td class='lessen'>35</td><td>FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN</td><td></td><td>21</td><td>0.41</td><td>1.71</td><td>0.024</td><td>0.077</td><td>0.913</td><td>126</td><td>tags=62%, list=31%, signal=85%</td></tr><tr><td class='lessen'>36</td><td>MARSON_BOUND_BY_FOXP3_UNSTIMULATED</td><td></td><td>30</td><td>0.36</td><td>1.68</td><td>0.022</td><td>0.090</td><td>0.948</td><td>115</td><td>tags=53%, list=28%, signal=69%</td></tr><tr><td class='lessen'>37</td><td>VERHAAK_GLIOBLASTOMA_MESENCHYMAL</td><td></td><td>21</td><td>0.40</td><td>1.65</td><td>0.023</td><td>0.104</td><td>0.969</td><td>118</td><td>tags=62%, list=29%, signal=83%</td></tr><tr><td class='lessen'>38</td><td>WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D</td><td></td><td>32</td><td>0.34</td><td>1.64</td><td>0.017</td><td>0.107</td><td>0.972</td><td>45</td><td>tags=31%, list=11%, signal=32%</td></tr><tr><td class='lessen'>39</td><td>ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY</td><td></td><td>26</td><td>0.36</td><td>1.61</td><td>0.035</td><td>0.124</td><td>0.984</td><td>122</td><td>tags=54%, list=30%, signal=72%</td></tr><tr><td class='lessen'>40</td><td>CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN</td><td></td><td>15</td><td>0.42</td><td>1.60</td><td>0.058</td><td>0.132</td><td>0.989</td><td>110</td><td>tags=53%, list=27%, signal=71%</td></tr><tr><td class='lessen'>41</td><td>RODWELL_AGING_KIDNEY_UP</td><td></td><td>23</td><td>0.36</td><td>1.59</td><td>0.044</td><td>0.131</td><td>0.989</td><td>124</td><td>tags=57%, list=31%, signal=77%</td></tr><tr><td class='lessen'>42</td><td>GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN</td><td></td><td>30</td><td>0.33</td><td>1.56</td><td>0.047</td><td>0.151</td><td>0.993</td><td>126</td><td>tags=53%, list=31%, signal=72%</td></tr><tr><td class='lessen'>43</td><td>REACTOME_IMMUNE_SYSTEM</td><td></td><td>29</td><td>0.34</td><td>1.56</td><td>0.031</td><td>0.149</td><td>0.993</td><td>94</td><td>tags=45%, list=23%, signal=54%</td></tr><tr><td class='lessen'>44</td><td>DANG_REGULATED_BY_MYC_DN</td><td></td><td>16</td><td>0.40</td><td>1.56</td><td>0.057</td><td>0.146</td><td>0.993</td><td>103</td><td>tags=50%, list=25%, signal=64%</td></tr><tr><td class='lessen'>45</td><td>CHICAS_RB1_TARGETS_CONFLUENT</td><td></td><td>26</td><td>0.34</td><td>1.55</td><td>0.049</td><td>0.147</td><td>0.995</td><td>78</td><td>tags=42%, list=19%, signal=49%</td></tr><tr><td class='lessen'>46</td><td>PEDRIOLI_MIR31_TARGETS_DN</td><td></td><td>18</td><td>0.39</td><td>1.55</td><td>0.049</td><td>0.149</td><td>0.995</td><td>177</td><td>tags=83%, list=44%, signal=141%</td></tr><tr><td class='lessen'>47</td><td>DELYS_THYROID_CANCER_UP</td><td></td><td>19</td><td>0.38</td><td>1.54</td><td>0.054</td><td>0.152</td><td>0.996</td><td>42</td><td>tags=37%, list=10%, signal=39%</td></tr><tr><td class='lessen'>48</td><td>REN_ALVEOLAR_RHABDOMYOSARCOMA_DN</td><td></td><td>27</td><td>0.33</td><td>1.53</td><td>0.061</td><td>0.160</td><td>0.999</td><td>137</td><td>tags=59%, list=34%, signal=84%</td></tr><tr><td class='lessen'>49</td><td>SCHLOSSER_SERUM_RESPONSE_DN</td><td></td><td>21</td><td>0.36</td><td>1.52</td><td>0.067</td><td>0.160</td><td>0.999</td><td>188</td><td>tags=76%, list=46%, signal=135%</td></tr><tr><td class='lessen'>50</td><td>GEORGES_TARGETS_OF_MIR192_AND_MIR215</td><td></td><td>20</td><td>0.36</td><td>1.52</td><td>0.073</td><td>0.158</td><td>0.999</td><td>118</td><td>tags=55%, list=29%, signal=74%</td></tr><tr><td class='lessen'>51</td><td>THUM_SYSTOLIC_HEART_FAILURE_UP</td><td></td><td>18</td><td>0.38</td><td>1.52</td><td>0.070</td><td>0.160</td><td>0.999</td><td>159</td><td>tags=61%, list=39%, signal=96%</td></tr><tr><td class='lessen'>52</td><td>SHEN_SMARCA2_TARGETS_UP</td><td></td><td>19</td><td>0.38</td><td>1.52</td><td>0.054</td><td>0.158</td><td>0.999</td><td>228</td><td>tags=95%, list=56%, signal=207%</td></tr><tr><td class='lessen'>53</td><td>RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN</td><td></td><td>18</td><td>0.37</td><td>1.50</td><td>0.064</td><td>0.167</td><td>0.999</td><td>77</td><td>tags=44%, list=19%, signal=52%</td></tr><tr><td class='lessen'>54</td><td>KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP</td><td></td><td>46</td><td>0.28</td><td>1.50</td><td>0.054</td><td>0.165</td><td>0.999</td><td>118</td><td>tags=48%, list=29%, signal=60%</td></tr><tr><td class='lessen'>55</td><td>MCLACHLAN_DENTAL_CARIES_UP</td><td></td><td>17</td><td>0.38</td><td>1.49</td><td>0.064</td><td>0.168</td><td>0.999</td><td>107</td><td>tags=53%, list=26%, signal=69%</td></tr><tr><td class='lessen'>56</td><td>LEE_BMP2_TARGETS_UP</td><td></td><td>27</td><td>0.33</td><td>1.48</td><td>0.070</td><td>0.171</td><td>0.999</td><td>126</td><td>tags=56%, list=31%, signal=75%</td></tr><tr><td class='lessen'>57</td><td>DACOSTA_UV_RESPONSE_VIA_ERCC3_DN</td><td></td><td>15</td><td>0.39</td><td>1.48</td><td>0.088</td><td>0.169</td><td>0.999</td><td>92</td><td>tags=47%, list=23%, signal=58%</td></tr><tr><td class='lessen'>58</td><td>RUTELLA_RESPONSE_TO_HGF_UP</td><td></td><td>27</td><td>0.31</td><td>1.45</td><td>0.078</td><td>0.191</td><td>1.000</td><td>132</td><td>tags=56%, list=33%, signal=77%</td></tr><tr><td class='lessen'>59</td><td>ODONNELL_TFRC_TARGETS_UP</td><td></td><td>18</td><td>0.36</td><td>1.43</td><td>0.093</td><td>0.216</td><td>1.000</td><td>116</td><td>tags=61%, list=29%, signal=82%</td></tr><tr><td class='lessen'>60</td><td>MILI_PSEUDOPODIA_CHEMOTAXIS_DN</td><td></td><td>21</td><td>0.34</td><td>1.41</td><td>0.102</td><td>0.223</td><td>1.000</td><td>116</td><td>tags=48%, list=29%, signal=63%</td></tr><tr><td class='lessen'>61</td><td>KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3</td><td></td><td>31</td><td>0.30</td><td>1.41</td><td>0.094</td><td>0.220</td><td>1.000</td><td>88</td><td>tags=39%, list=22%, signal=46%</td></tr><tr><td class='lessen'>62</td><td>SWEET_LUNG_CANCER_KRAS_UP</td><td></td><td>21</td><td>0.33</td><td>1.40</td><td>0.101</td><td>0.228</td><td>1.000</td><td>132</td><td>tags=52%, list=33%, signal=74%</td></tr><tr><td class='lessen'>63</td><td>BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS</td><td></td><td>24</td><td>0.32</td><td>1.40</td><td>0.116</td><td>0.227</td><td>1.000</td><td>167</td><td>tags=67%, list=41%, signal=107%</td></tr><tr><td class='lessen'>64</td><td>BROWNE_HCMV_INFECTION_48HR_DN</td><td></td><td>16</td><td>0.36</td><td>1.40</td><td>0.125</td><td>0.226</td><td>1.000</td><td>90</td><td>tags=44%, list=22%, signal=54%</td></tr><tr><td class='lessen'>65</td><td>PUJANA_ATM_PCC_NETWORK</td><td></td><td>42</td><td>0.27</td><td>1.38</td><td>0.099</td><td>0.240</td><td>1.000</td><td>87</td><td>tags=33%, list=21%, signal=38%</td></tr><tr><td class='lessen'>66</td><td>OSMAN_BLADDER_CANCER_DN</td><td></td><td>17</td><td>0.35</td><td>1.38</td><td>0.128</td><td>0.240</td><td>1.000</td><td>87</td><td>tags=41%, list=21%, signal=50%</td></tr><tr><td class='lessen'>67</td><td>REACTOME_ADAPTIVE_IMMUNE_SYSTEM</td><td></td><td>16</td><td>0.36</td><td>1.38</td><td>0.112</td><td>0.238</td><td>1.000</td><td>91</td><td>tags=44%, list=22%, signal=54%</td></tr><tr><td class='lessen'>68</td><td>DACOSTA_UV_RESPONSE_VIA_ERCC3_UP</td><td></td><td>15</td><td>0.37</td><td>1.37</td><td>0.137</td><td>0.242</td><td>1.000</td><td>89</td><td>tags=53%, list=22%, signal=66%</td></tr><tr><td class='lessen'>69</td><td>LI_INDUCED_T_TO_NATURAL_KILLER_UP</td><td></td><td>17</td><td>0.34</td><td>1.34</td><td>0.158</td><td>0.266</td><td>1.000</td><td>77</td><td>tags=41%, list=19%, signal=49%</td></tr><tr><td class='lessen'>70</td><td>MARTINEZ_RB1_AND_TP53_TARGETS_UP</td><td></td><td>23</td><td>0.30</td><td>1.32</td><td>0.143</td><td>0.291</td><td>1.000</td><td>177</td><td>tags=65%, list=44%, signal=109%</td></tr><tr><td class='lessen'>71</td><td>ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP</td><td></td><td>32</td><td>0.26</td><td>1.29</td><td>0.168</td><td>0.321</td><td>1.000</td><td>114</td><td>tags=44%, list=28%, signal=56%</td></tr><tr><td class='lessen'>72</td><td>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5</td><td></td><td>20</td><td>0.31</td><td>1.28</td><td>0.184</td><td>0.327</td><td>1.000</td><td>213</td><td>tags=85%, list=53%, signal=170%</td></tr><tr><td class='lessen'>73</td><td>ACEVEDO_LIVER_CANCER_UP</td><td></td><td>33</td><td>0.26</td><td>1.28</td><td>0.172</td><td>0.327</td><td>1.000</td><td>129</td><td>tags=48%, list=32%, signal=65%</td></tr><tr><td class='lessen'>74</td><td>OSMAN_BLADDER_CANCER_UP</td><td></td><td>16</td><td>0.34</td><td>1.28</td><td>0.182</td><td>0.325</td><td>1.000</td><td>126</td><td>tags=56%, list=31%, signal=78%</td></tr><tr><td class='lessen'>75</td><td>LEI_MYB_TARGETS</td><td></td><td>21</td><td>0.29</td><td>1.22</td><td>0.232</td><td>0.394</td><td>1.000</td><td>143</td><td>tags=62%, list=35%, signal=91%</td></tr><tr><td class='lessen'>76</td><td>GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP</td><td></td><td>45</td><td>0.22</td><td>1.22</td><td>0.208</td><td>0.397</td><td>1.000</td><td>103</td><td>tags=36%, list=25%, signal=42%</td></tr><tr><td class='lessen'>77</td><td>CHYLA_CBFA2T3_TARGETS_UP</td><td></td><td>18</td><td>0.30</td><td>1.20</td><td>0.233</td><td>0.415</td><td>1.000</td><td>118</td><td>tags=56%, list=29%, signal=75%</td></tr><tr><td class='lessen'>78</td><td>WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D</td><td></td><td>26</td><td>0.26</td><td>1.20</td><td>0.244</td><td>0.415</td><td>1.000</td><td>84</td><td>tags=38%, list=21%, signal=45%</td></tr><tr><td class='lessen'>79</td><td>DODD_NASOPHARYNGEAL_CARCINOMA_UP</td><td></td><td>35</td><td>0.24</td><td>1.20</td><td>0.217</td><td>0.411</td><td>1.000</td><td>82</td><td>tags=31%, list=20%, signal=36%</td></tr><tr><td class='lessen'>80</td><td>ALFANO_MYC_TARGETS</td><td></td><td>15</td><td>0.31</td><td>1.19</td><td>0.254</td><td>0.420</td><td>1.000</td><td>103</td><td>tags=47%, list=25%, signal=60%</td></tr><tr><td class='lessen'>81</td><td>LIM_MAMMARY_STEM_CELL_DN</td><td></td><td>17</td><td>0.29</td><td>1.15</td><td>0.276</td><td>0.475</td><td>1.000</td><td>100</td><td>tags=41%, list=25%, signal=52%</td></tr><tr><td class='lessen'>82</td><td>TARTE_PLASMA_CELL_VS_PLASMABLAST_DN</td><td></td><td>16</td><td>0.30</td><td>1.14</td><td>0.284</td><td>0.477</td><td>1.000</td><td>129</td><td>tags=50%, list=32%, signal=70%</td></tr><tr><td class='lessen'>83</td><td>YOSHIMURA_MAPK8_TARGETS_UP</td><td></td><td>31</td><td>0.23</td><td>1.14</td><td>0.276</td><td>0.477</td><td>1.000</td><td>77</td><td>tags=32%, list=19%, signal=37%</td></tr><tr><td class='lessen'>84</td><td>FEVR_CTNNB1_TARGETS_DN</td><td></td><td>15</td><td>0.31</td><td>1.12</td><td>0.334</td><td>0.500</td><td>1.000</td><td>51</td><td>tags=27%, list=13%, signal=29%</td></tr><tr><td class='lessen'>85</td><td>PILON_KLF1_TARGETS_DN</td><td></td><td>79</td><td>0.18</td><td>1.11</td><td>0.312</td><td>0.508</td><td>1.000</td><td>166</td><td>tags=48%, list=41%, signal=66%</td></tr><tr><td class='lessen'>86</td><td>WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN</td><td></td><td>21</td><td>0.26</td><td>1.10</td><td>0.340</td><td>0.525</td><td>1.000</td><td>80</td><td>tags=33%, list=20%, signal=39%</td></tr><tr><td class='lessen'>87</td><td>HOSHIDA_LIVER_CANCER_SUBCLASS_S3</td><td></td><td>15</td><td>0.30</td><td>1.09</td><td>0.360</td><td>0.542</td><td>1.000</td><td>36</td><td>tags=27%, list=9%, signal=28%</td></tr><tr><td class='lessen'>88</td><td>MARTINEZ_TP53_TARGETS_UP</td><td></td><td>21</td><td>0.26</td><td>1.08</td><td>0.343</td><td>0.541</td><td>1.000</td><td>191</td><td>tags=67%, list=47%, signal=120%</td></tr><tr><td class='lessen'>89</td><td>FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP</td><td></td><td>32</td><td>0.22</td><td>1.08</td><td>0.358</td><td>0.536</td><td>1.000</td><td>29</td><td>tags=19%, list=7%, signal=19%</td></tr><tr><td class='lessen'>90</td><td>BERENJENO_TRANSFORMED_BY_RHOA_DN</td><td></td><td>20</td><td>0.26</td><td>1.07</td><td>0.405</td><td>0.556</td><td>1.000</td><td>48</td><td>tags=25%, list=12%, signal=27%</td></tr><tr><td class='lessen'>91</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN</td><td></td><td>19</td><td>0.26</td><td>1.07</td><td>0.371</td><td>0.551</td><td>1.000</td><td>199</td><td>tags=74%, list=49%, signal=138%</td></tr><tr><td class='lessen'>92</td><td>BLALOCK_ALZHEIMERS_DISEASE_UP</td><td></td><td>60</td><td>0.18</td><td>1.06</td><td>0.383</td><td>0.547</td><td>1.000</td><td>63</td><td>tags=23%, list=16%, signal=24%</td></tr><tr><td class='lessen'>93</td><td>JOHNSTONE_PARVB_TARGETS_3_DN</td><td></td><td>23</td><td>0.24</td><td>1.06</td><td>0.375</td><td>0.549</td><td>1.000</td><td>165</td><td>tags=57%, list=41%, signal=90%</td></tr><tr><td class='lessen'>94</td><td>BASAKI_YBX1_TARGETS_DN</td><td></td><td>15</td><td>0.27</td><td>1.04</td><td>0.403</td><td>0.580</td><td>1.000</td><td>88</td><td>tags=40%, list=22%, signal=49%</td></tr><tr><td class='lessen'>95</td><td>REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS</td><td></td><td>18</td><td>0.25</td><td>1.03</td><td>0.428</td><td>0.589</td><td>1.000</td><td>104</td><td>tags=44%, list=26%, signal=57%</td></tr><tr><td class='lessen'>96</td><td>ACEVEDO_LIVER_CANCER_DN</td><td></td><td>18</td><td>0.25</td><td>1.00</td><td>0.447</td><td>0.633</td><td>1.000</td><td>51</td><td>tags=28%, list=13%, signal=30%</td></tr><tr><td class='lessen'>97</td><td>GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS</td><td></td><td>33</td><td>0.20</td><td>1.00</td><td>0.467</td><td>0.631</td><td>1.000</td><td>81</td><td>tags=30%, list=20%, signal=35%</td></tr><tr><td class='lessen'>98</td><td>THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN</td><td></td><td>15</td><td>0.26</td><td>0.99</td><td>0.485</td><td>0.634</td><td>1.000</td><td>80</td><td>tags=33%, list=20%, signal=40%</td></tr><tr><td class='lessen'>99</td><td>LIU_SOX4_TARGETS_DN</td><td></td><td>17</td><td>0.25</td><td>0.97</td><td>0.479</td><td>0.665</td><td>1.000</td><td>308</td><td>tags=100%, list=76%, signal=400%</td></tr><tr><td class='lessen'>100</td><td>NUYTTEN_NIPP1_TARGETS_UP</td><td></td><td>17</td><td>0.25</td><td>0.97</td><td>0.484</td><td>0.662</td><td>1.000</td><td>119</td><td>tags=47%, list=29%, signal=64%</td></tr><tr><td class='lessen'>101</td><td>GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP</td><td></td><td>16</td><td>0.24</td><td>0.94</td><td>0.518</td><td>0.695</td><td>1.000</td><td>115</td><td>tags=44%, list=28%, signal=59%</td></tr><tr><td class='lessen'>102</td><td>WEI_MYCN_TARGETS_WITH_E_BOX</td><td></td><td>22</td><td>0.21</td><td>0.94</td><td>0.520</td><td>0.691</td><td>1.000</td><td>98</td><td>tags=32%, list=24%, signal=40%</td></tr><tr><td class='lessen'>103</td><td>FORTSCHEGGER_PHF8_TARGETS_DN</td><td></td><td>21</td><td>0.22</td><td>0.93</td><td>0.529</td><td>0.698</td><td>1.000</td><td>194</td><td>tags=67%, list=48%, signal=121%</td></tr><tr><td class='lessen'>104</td><td>RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP</td><td></td><td>15</td><td>0.24</td><td>0.93</td><td>0.523</td><td>0.702</td><td>1.000</td><td>154</td><td>tags=53%, list=38%, signal=83%</td></tr><tr><td class='lessen'>105</td><td>MARTINEZ_RB1_TARGETS_UP</td><td></td><td>23</td><td>0.21</td><td>0.93</td><td>0.569</td><td>0.697</td><td>1.000</td><td>176</td><td>tags=57%, list=43%, signal=94%</td></tr><tr><td class='lessen'>106</td><td>IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR</td><td></td><td>25</td><td>0.20</td><td>0.91</td><td>0.590</td><td>0.723</td><td>1.000</td><td>106</td><td>tags=40%, list=26%, signal=51%</td></tr><tr><td class='lessen'>107</td><td>BENPORATH_NANOG_TARGETS</td><td></td><td>26</td><td>0.20</td><td>0.91</td><td>0.566</td><td>0.718</td><td>1.000</td><td>60</td><td>tags=23%, list=15%, signal=25%</td></tr><tr><td class='lessen'>108</td><td>RIGGI_EWING_SARCOMA_PROGENITOR_UP</td><td></td><td>15</td><td>0.24</td><td>0.90</td><td>0.579</td><td>0.732</td><td>1.000</td><td>95</td><td>tags=40%, list=23%, signal=50%</td></tr><tr><td class='lessen'>109</td><td>PATIL_LIVER_CANCER</td><td></td><td>28</td><td>0.19</td><td>0.88</td><td>0.629</td><td>0.750</td><td>1.000</td><td>152</td><td>tags=50%, list=38%, signal=75%</td></tr><tr><td class='lessen'>110</td><td>LOPEZ_MBD_TARGETS</td><td></td><td>41</td><td>0.17</td><td>0.88</td><td>0.627</td><td>0.746</td><td>1.000</td><td>137</td><td>tags=46%, list=34%, signal=63%</td></tr><tr><td class='lessen'>111</td><td>ONKEN_UVEAL_MELANOMA_DN</td><td></td><td>20</td><td>0.19</td><td>0.80</td><td>0.688</td><td>0.866</td><td>1.000</td><td>178</td><td>tags=55%, list=44%, signal=93%</td></tr><tr><td class='lessen'>112</td><td>FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP</td><td></td><td>18</td><td>0.20</td><td>0.80</td><td>0.716</td><td>0.866</td><td>1.000</td><td>132</td><td>tags=44%, list=33%, signal=63%</td></tr><tr><td class='lessen'>113</td><td>MILI_PSEUDOPODIA_HAPTOTAXIS_DN</td><td></td><td>34</td><td>0.16</td><td>0.80</td><td>0.746</td><td>0.862</td><td>1.000</td><td>120</td><td>tags=35%, list=30%, signal=46%</td></tr><tr><td class='lessen'>114</td><td>ENK_UV_RESPONSE_KERATINOCYTE_DN</td><td></td><td>15</td><td>0.21</td><td>0.79</td><td>0.723</td><td>0.857</td><td>1.000</td><td>322</td><td>tags=100%, list=80%, signal=470%</td></tr><tr><td class='lessen'>115</td><td>HELLER_HDAC_TARGETS_UP</td><td></td><td>17</td><td>0.20</td><td>0.77</td><td>0.738</td><td>0.879</td><td>1.000</td><td>168</td><td>tags=59%, list=41%, signal=96%</td></tr><tr><td class='lessen'>116</td><td>GARY_CD5_TARGETS_UP</td><td></td><td>24</td><td>0.17</td><td>0.76</td><td>0.779</td><td>0.891</td><td>1.000</td><td>193</td><td>tags=58%, list=48%, signal=105%</td></tr><tr><td class='lessen'>117</td><td>MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN</td><td></td><td>16</td><td>0.19</td><td>0.74</td><td>0.791</td><td>0.908</td><td>1.000</td><td>121</td><td>tags=38%, list=30%, signal=51%</td></tr><tr><td class='lessen'>118</td><td>BLALOCK_ALZHEIMERS_DISEASE_DN</td><td></td><td>46</td><td>0.14</td><td>0.74</td><td>0.832</td><td>0.909</td><td>1.000</td><td>52</td><td>tags=17%, list=13%, signal=18%</td></tr><tr><td class='lessen'>119</td><td>RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP</td><td></td><td>17</td><td>0.19</td><td>0.73</td><td>0.799</td><td>0.908</td><td>1.000</td><td>40</td><td>tags=18%, list=10%, signal=19%</td></tr><tr><td class='lessen'>120</td><td>GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP</td><td></td><td>22</td><td>0.17</td><td>0.72</td><td>0.812</td><td>0.916</td><td>1.000</td><td>122</td><td>tags=36%, list=30%, signal=49%</td></tr><tr><td class='lessen'>121</td><td>STEIN_ESRRA_TARGETS</td><td></td><td>20</td><td>0.17</td><td>0.72</td><td>0.809</td><td>0.912</td><td>1.000</td><td>29</td><td>tags=15%, list=7%, signal=15%</td></tr><tr><td class='lessen'>122</td><td>TIEN_INTESTINE_PROBIOTICS_24HR_UP</td><td></td><td>20</td><td>0.17</td><td>0.71</td><td>0.830</td><td>0.916</td><td>1.000</td><td>191</td><td>tags=60%, list=47%, signal=108%</td></tr><tr><td class='lessen'>123</td><td>PEREZ_TP53_TARGETS</td><td></td><td>18</td><td>0.17</td><td>0.69</td><td>0.846</td><td>0.932</td><td>1.000</td><td>77</td><td>tags=28%, list=19%, signal=33%</td></tr><tr><td class='lessen'>124</td><td>KRIEG_HYPOXIA_NOT_VIA_KDM3A</td><td></td><td>35</td><td>0.14</td><td>0.69</td><td>0.883</td><td>0.925</td><td>1.000</td><td>92</td><td>tags=29%, list=23%, signal=34%</td></tr><tr><td class='lessen'>125</td><td>RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP</td><td></td><td>18</td><td>0.17</td><td>0.68</td><td>0.832</td><td>0.923</td><td>1.000</td><td>9</td><td>tags=11%, list=2%, signal=11%</td></tr><tr><td class='lessen'>126</td><td>DELACROIX_RAR_BOUND_ES</td><td></td><td>15</td><td>0.18</td><td>0.66</td><td>0.893</td><td>0.933</td><td>1.000</td><td>81</td><td>tags=27%, list=20%, signal=32%</td></tr><tr><td class='lessen'>127</td><td>SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6</td><td></td><td>19</td><td>0.16</td><td>0.65</td><td>0.884</td><td>0.939</td><td>1.000</td><td>161</td><td>tags=47%, list=40%, signal=75%</td></tr><tr><td class='lessen'>128</td><td>KIM_ALL_DISORDERS_CALB1_CORR_UP</td><td></td><td>19</td><td>0.16</td><td>0.65</td><td>0.894</td><td>0.936</td><td>1.000</td><td>238</td><td>tags=79%, list=59%, signal=182%</td></tr><tr><td class='lessen'>129</td><td>WANG_LMO4_TARGETS_UP</td><td></td><td>19</td><td>0.16</td><td>0.64</td><td>0.907</td><td>0.935</td><td>1.000</td><td>132</td><td>tags=37%, list=33%, signal=52%</td></tr><tr><td class='lessen'>130</td><td>FISCHER_DREAM_TARGETS</td><td></td><td>20</td><td>0.12</td><td>0.49</td><td>0.977</td><td>1.000</td><td>1.000</td><td>71</td><td>tags=20%, list=18%, signal=23%</td></tr><tr><td class='lessen'>131</td><td>BRUINS_UVC_RESPONSE_LATE</td><td></td><td>27</td><td>0.11</td><td>0.49</td><td>0.985</td><td>1.000</td><td>1.000</td><td>92</td><td>tags=26%, list=23%, signal=31%</td></tr><tr><td class='lessen'>132</td><td>GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP</td><td></td><td>17</td><td>0.12</td><td>0.46</td><td>0.988</td><td>1.000</td><td>1.000</td><td>88</td><td>tags=24%, list=22%, signal=29%</td></tr><tr><td class='lessen'>133</td><td>REACTOME_METABOLISM_OF_CARBOHYDRATES</td><td></td><td>15</td><td>0.12</td><td>0.46</td><td>0.989</td><td>0.998</td><td>1.000</td><td>4</td><td>tags=7%, list=1%, signal=6%</td></tr><tr><td class='lessen'>134</td><td>PUJANA_BRCA1_PCC_NETWORK</td><td></td><td>43</td><td>0.08</td><td>0.42</td><td>0.997</td><td>0.996</td><td>1.000</td><td>328</td><td>tags=93%, list=81%, signal=437%</td></tr><caption class='table'>Table: Gene sets enriched in phenotype <b>REST (6 samples)<b>&nbsp<a href='gsea_report_for_REST_1549053414829.xls'>[plain text format]</a></caption></table></div><br></body></html>